TY - JOUR
T1 - Cardiac arrhythmia services in Africa from 2011 to 2018
T2 - The second report from the Pan African Society of Cardiology working group on cardiac arrhythmias and pacing
AU - Bonny, Aimé
AU - Ngantcha, Marcus
AU - Yuyun, Matthew
AU - Karaye, Kamilu M.
AU - Scholtz, Wihan
AU - Suliman, Ahmed
AU - Nel, George
AU - Aoudia, Yazid
AU - Kane, Adama
AU - Moustaghfi, Abdelhamid
AU - Okello, Emmy
AU - Houenassi, Martin
AU - Sonou, Arn
AU - Niakara, Ali
AU - Lubenga, Yves Ray
AU - Adoubi, Anicet
AU - Russel, James
AU - Damasceno, Albertino
AU - Touré, Ali Ibrahim
AU - Kane, Abdoul
AU - Tabane, Alioune
AU - Jeilan, Mohammed
AU - Mbaye, Alassane
AU - Tibazarwa, Kemi
AU - Ben Ameur, Yousef
AU - Diakité, Mamadou
AU - Subahi, Saad
AU - Kaviraj, Bundhoo
AU - Sani, Mahmoud U.
AU - Ajijola, Olujimi A.
AU - Chin, Ashley
AU - Sliwa, Karen
N1 - Publisher Copyright:
© 2020 Published on behalf of the European Society of Cardiology. All rights reserved.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Aims: Cardiac arrhythmia services are a neglected field of cardiology in Africa. To provide comprehensive contemporary information on the access and use of cardiac arrhythmia services in Africa. Methods and results: Data on human resources, drug availability, cardiac implantable electronic devices (CIED), and ablation procedures were sought from member countries of Pan African Society of Cardiology. Data were received from 23 out of 31 countries. In most countries, healthcare services are primarily supported by household incomes. Vitamin K antagonists (VKAs), digoxin, and amiodarone were available in all countries, while the availability of other drugs varied widely. Non-VKA oral anticoagulants (NOACs) were unequally present in the African markets, while International Normalized Ratio monitoring was challenging. Four countries (18%) did not provide pacemaker implantations while, where available, the implantation and operator rates were 2.79 and 0.772 per million population, respectively. The countries with the highest pacemaker implantation rate/million population in descending order were Tunisia, Mauritius, South Africa, Algeria, and Morocco. Implantable cardioverter-defibrillator and cardiac resynchronization therapy (CRT) were performed in 15 (65%) and 12 (52%) countries, respectively. Reconditioned CIED were used in 5 (22%) countries. Electrophysiology was performed in 8 (35%) countries, but complex ablations only in countries from the Maghreb and South Africa. Marked variation in costs of CIED that severely mismatched the gross domestic product per capita was observed in Africa. From the first report, three countries have started performing simple ablations. Conclusion: The access to arrhythmia treatments varied widely in Africa where hundreds of millions of people remain at risk of dying from heart block. Increased economic and human resources as well as infrastructures are the critical targets for improving arrhythmia services in Africa.
AB - Aims: Cardiac arrhythmia services are a neglected field of cardiology in Africa. To provide comprehensive contemporary information on the access and use of cardiac arrhythmia services in Africa. Methods and results: Data on human resources, drug availability, cardiac implantable electronic devices (CIED), and ablation procedures were sought from member countries of Pan African Society of Cardiology. Data were received from 23 out of 31 countries. In most countries, healthcare services are primarily supported by household incomes. Vitamin K antagonists (VKAs), digoxin, and amiodarone were available in all countries, while the availability of other drugs varied widely. Non-VKA oral anticoagulants (NOACs) were unequally present in the African markets, while International Normalized Ratio monitoring was challenging. Four countries (18%) did not provide pacemaker implantations while, where available, the implantation and operator rates were 2.79 and 0.772 per million population, respectively. The countries with the highest pacemaker implantation rate/million population in descending order were Tunisia, Mauritius, South Africa, Algeria, and Morocco. Implantable cardioverter-defibrillator and cardiac resynchronization therapy (CRT) were performed in 15 (65%) and 12 (52%) countries, respectively. Reconditioned CIED were used in 5 (22%) countries. Electrophysiology was performed in 8 (35%) countries, but complex ablations only in countries from the Maghreb and South Africa. Marked variation in costs of CIED that severely mismatched the gross domestic product per capita was observed in Africa. From the first report, three countries have started performing simple ablations. Conclusion: The access to arrhythmia treatments varied widely in Africa where hundreds of millions of people remain at risk of dying from heart block. Increased economic and human resources as well as infrastructures are the critical targets for improving arrhythmia services in Africa.
KW - Ablation
KW - Africa
KW - Cardiac Arrhythmia Service
KW - Cardiac arrhythmias
KW - Cardiac implantable electronic devices
KW - Drug therapy
KW - Electrophysiology
UR - https://www.scopus.com/pages/publications/85081741835
U2 - 10.1093/europace/euz354
DO - 10.1093/europace/euz354
M3 - Article
C2 - 31989158
AN - SCOPUS:85081741835
SN - 1099-5129
VL - 22
SP - 420
EP - 433
JO - Europace
JF - Europace
IS - 3
ER -